Advances of Theranostics of 2019-nCoV [PDF]
openaire +2 more sources
Dynamical analysis and numerical assessment of the 2019-nCoV virus transmission with optimal control. [PDF]
Li S +4 more
europepmc +1 more source
Antiviral drugs suppress infection of 2019-nCoV spike pseudotyped virus by interacting with ACE2 protein. [PDF]
Wang J +6 more
europepmc +1 more source
This interim guidance is based on what is currently known about 2019 novel coronavirus (2019-nCoV) and transmission of other viral respiratory infections.
core
Evaluation of the RHAM-based Pluslife Rapid SARS-CoV-2 assay and comparison with EasyNAT Rapid SARS-CoV-2 assay and Wondfo 2019-nCoV antigen assay. [PDF]
Zhong G +9 more
europepmc +1 more source
Origins of MERS-CoV, and lessons for 2019-nCoV [PDF]
openaire +2 more sources
2019-nCoV situation summary 2019 novel coronavirus (2019-nCoV) in the U.S : updated February 3, 2020
This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Updated February 3, 2020CDC is closely monitoring an outbreak of respiratory illness caused by a novel (new)
core
Comparison of two polymerase chain reaction assays, DaAn Gene (DaAn Gene 2019-ncov) and Cepheid (Cepheid Xpert Xpress SARS-CoV-2) for Delta and Omicron variants of SARS-CoV-2 detection in Yaoundé, Cameroon. [PDF]
Maidadi-Foudi M +22 more
europepmc +1 more source
Instructions for completion of the human infection with 2019 novel coronavirus (2019-nCoV) case report form [PDF]
Version 5 FEB 2020Purpose: This document describes the procedures for completing the 2019 Novel Coronavirus (2019-nCoV) Case Report Form (CRF) for laboratory-confirmed cases of 2019-nCoV ...
core
Aptamer-Gated Mesoporous Silica Nanoparticles for N Protein Triggered Release of Remdesivir and Treatment of Novel Coronavirus (2019-nCoV). [PDF]
Zhang X +10 more
europepmc +1 more source

